Pursuant to Directive No. 10-07, “Mass Torts – Revised Guidelines and Criteria for Designation,” an application has been made to the Supreme Court, through the Acting Administrative Director of the Courts, for designation of all litigation involving the antibiotic drug Levaquin as a mass tort and assignment for centralized management in Atlantic County.
Anyone wishing to comment on or object to this application should provide such comments or objections, with relevant supporting documentation, to the Acting Administrative Director of the Courts, P. O. Box 037, Trenton, NJ 08625-0037, by Friday, June 5, 2009.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]